Danaher (DHR) Surges 3.4%: Is This an Indication of Further Gains?Zacks Investment Research • 04/14/21
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDAPRNewsWire • 03/23/21
Beckman Coulter Offers $4/High-throughput Antigen Test to Support U.S. Government Initiative to Expand COVID-19 TestingPRNewsWire • 03/18/21
Danaher Corporation (DHR) Management Presents at Barclays Global Healthcare Conference (Transcript)Seeking Alpha • 03/11/21
IDT Acquires Swift Biosciences, a Pioneer in the Development of Next-Generation Sequencing (NGS) Library Preparation Genomics Kits for Academic, Translational, and Clinical ResearchBusiness Wire • 03/11/21